Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 33 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 10981915

    Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

    Valo Early Discovery, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  2. US 10981906

    Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same

    Aclaris Therapeutics, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  3. US 10980889

    C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

    Revolution Medicines, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  4. US 10980797

    Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

    Corcept Therapeutics Incorporated · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  5. US 10981860

    Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof

    Medshine Discovery Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  6. US 10981896

    Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  7. US 10980793

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  8. US 10975064

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  9. US 10973830

    Substituted quinoxaline DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  10. US 10975166

    Inhibitory antibodies against MMP-14

    The Regents of the University of California · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  11. US 10975094

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  12. US 10975167

    Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  13. US 10968222

    2-azabicyclo hexane JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  14. US 10968205

    Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  15. US 10968180

    Piperidine derivatives as HDAC1/2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  16. US 10968178

    IP6K inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  17. US 10966977

    Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders

    TG Therapeutics, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  18. US 10959984

    Methods for treating cancer with RORγ inhibitors

    The Regents of the University of California · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  19. US 10961267

    Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease

    Theravance Biopharma R&D IP, LLC · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  20. US 10961200

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  21. US 10961232

    Substituted pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  22. US 10953209

    Treating tumors using TTFields combined with a PARP inhibitor

    The Board of Regents of the University of Texas System · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  23. US 10952996

    ALK5 inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted
  24. US 10952997

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted